Company intelligence / Profile preview
Junhemeng Biopharmaceutical
Hangzhou, Zhejiang, Chinajhm-biopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Junhemeng Biopharmaceutical is a Chinese biotechnology company specializing in the development and commercialization of recombinant protein drugs and synthetic biology products. Founded in 2020, the company focuses on three core therapeutic areas: endocrinology, neurology, and tissue repair. Its lead pipeline candidates include recombinant human growth hormone (JHM01 and JHM02) and a recombinant type A botulinum toxin (JHM03), which is currently in Phase 3 clinical trials for adult upper limb spasticity and glabellar lines. Junhemeng operates vertically integrated GMP manufacturing facilities in Hangzhou and Tonghua to support its R&D and commercialization efforts. The company has secured significant venture capital funding to advance its portfolio of innovative biologics and medical devices.
- Therapeutic areas
- EndocrinologyOtherDermatologyNeurology
- Modalities
- Recombinant proteinBiologicPeptide
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Junhemeng Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Junhemeng Biopharmaceutical.